Checklist: 1
Each healthy individual possesses among these genes a functional alpha galactosidase acid gene as an enzyme that contributes to carbohydrate metabolism.
The DNA of an individual with Pompe disease has in his alpha galactosidase acid gene a loss of function due to a mutation which has made the encoded protein non-functional.
Checklist: 2
Pompe disease is a progressive and often fatal genetic disease related to an abnormal functioning of acidic alpha-1,4-glucosidase, a lysosomal enzyme that hydrolyzes glycogen to glucose.
This disease is responsible for muscle damage by abnormal glycogen metabolism. Since the defective enzyme is localized at the level of the lysosome, it is often classified as a lysosomal overload disease.
Checklist: 3
The accumulation of glycogen in the lysosomes of the skeletal muscles and the heart can cause lysosomal overload and lysosome destruction, leading eventually to cell destruction. This pathology can also affect other cells like the liver cells or the nerve cells.
The symptoms are different, it depends on the age. The most commonly observed signs are heart disease and breathing abnormalities leading to death if no care is taken.
Checklist: 4 and 5.
The available treatment is Enzyme Replacement Therapy
Enzyme Replacement Therapy (ERT) provides patients with a special form of alpha-glucosidase to replace the missing enzyme. This special form, called rhGAA, is produced from modified animal cells (a way to produce a large quantity of a quality enzyme needed for ERT).
Checklist: 6.
Unfortunately, the replacement therapy does not treat the disease itself, it only makes it possible to fill the enzymatic deficit caused by the disease, in order to improve the quality of life and prolong the life of the patient, because the cells will always remain incapable to synthesize the enzyme to the functional state by themselves.
The transplantation of bone marrow (in order to correct the deficit in the blood cells) has not been successful.